Fridge-Free Tetanus-Diphtheria (Td) Vaccine
Prophylaxis against Tetanus and Diphtheria
Phase 1Active
Key Facts
About Stablepharma
Stablepharma is pioneering the development of fridge-free vaccines and pharmaceuticals through its innovative StablevaX™ thermostabilization platform. The company is advancing a pipeline of reformulated vaccines, with its lead Tetanus-Diphtheria (Td) candidate having completed a Phase 1 clinical trial. By addressing the massive logistical and environmental costs of the global cold chain, Stablepharma targets significant public health impact and commercial opportunity in both developed and emerging markets, supported by grant funding and strategic partnerships.
View full company profileTherapeutic Areas
Other Prophylaxis against Tetanus and Diphtheria Drugs
| Drug | Company | Phase |
|---|---|---|
| Tetanus and Diphtheria Toxoid Vaccine | KM Biologics | Approved |